Biocorp

Actualités

Application of EUROIMMUN tests for COVID-19 diagnostics

Expiré
Détails
Catégorie : Actualités

Correct application of our tests

  • Identifi cation of an acute infection by direct virus detection by PCR:
    EURORealTime SARS-CoV-2
  • Further monitoring of patients with acute infection (confi rmed by positive PCR):
    Antibody detection using the Anti-SARS-CoV-2 ELISA (IgA)
  • Detection of a past contact with the pathogen (from 2 to 4 weeks after infection):
    Antibody detection using the Anti-SARS-CoV-2 ELISA (IgG)

Areas of application of EUROIMMUN SARS-CoV-2 tests

Interpretation of SARS-CoV-2 test results

Characteristics of EUROIMMUN SARS-CoV-2 tests

EURORealTime SARS-CoV-2 Anti-SARS-CoV-2 ELISA
  • High sensitivity and reliability due to simultaneous detection of two target sequences of SARS-CoV-2
  • IgG: High specifi city of 99 % * due to the use of the spike protein domain S1, which is hardly conserved within the coronavirus family; suitable for identifi cation of persons who had contact with the virus some time ago
  • Only one reaction per sample
  • IgA: Supportive analysis of follow-up samples after infection confi rmed by PCR; indicates a beginning immune reaction; not recommended for screening because of a limited specifi city of approx. 90 % in reference cohorts

 

* in various donor cohorts (samples taken before the outbreak of the COVID-19 pandemic), including blood donors, pregnant women, persons with
vaccinations, bacterial or viral infections or autoimmune diseases

 

Nous contacter

27, rue Abou Hamed Al Ghazali, Boulevard Rachidi,
Casablanca, Maroc

Tél: +212 522487216

Copyright © 2024 Biocorp